Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
Clémentine Schilte(Inserm), Matthew L. Albert(Radiant Genomics (United States)), Florence Guivel‐Benhassine(Centre National de la Recherche Scientifique), Olivier Schwartz(Centre National de la Recherche Scientifique), Marco Colonna(Washington University in St. Louis), Thérèse Couderc(Inserm), Marc Lecuit(Inserm), Nicolas Gangneux(Inserm), Anton Kraxner(Inserm), Lucie Peduto(Inserm), Stephen Higgs(The University of Texas Medical Branch at Galveston), Jürg Tschopp(University of Lausanne), Fabrice Chrétien(Institut Pasteur), Marion Sourisseau(Icahn School of Medicine at Mount Sinai), Fernando Arenzana‐Seisdedos(Department of Virology), Alain Michault(Centre Hospitalier Universitaire de La Réunion)
Cited by 314
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
|Autophagy|2016|6k
Guidelines for the use and interpretation of assays for monitoring autophagy
|Autophagy|2012|4.1k
Inhibition of death receptor signals by cellular FLIP
|Nature|1997|2.6k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997